Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | ap endonuclease, putative | 0.004 | 0.016 | 0.016 |
Mycobacterium leprae | DIHYDROLIPOAMIDE DEHYDROGENASE LPD (LIPOAMIDE REDUCTASE (NADH)) (LIPOYL DEHYDROGENASE) (DIHYDROLIPOYL DEHYDROGENASE) (DIAPHORASE | 0.0093 | 0.2094 | 0.4957 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.004 | 0.016 | 0.0571 |
Mycobacterium tuberculosis | Probable membrane NADH dehydrogenase NdhA | 0.0083 | 0.1754 | 0.2515 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.2179 | 0.7788 |
Brugia malayi | Thioredoxin reductase | 0.0037 | 0.0042 | 0.0151 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2179 | 0.7301 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Mycobacterium tuberculosis | Possible penicillin-binding protein | 0.0226 | 0.6971 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Mycobacterium tuberculosis | NAD(P)H quinone reductase LpdA | 0.0093 | 0.2094 | 0.3003 |
Echinococcus granulosus | thioredoxin glutathione reductase | 0.0037 | 0.006 | 0.0215 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2179 | 0.7301 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease, putative | 0.004 | 0.016 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.004 | 0.016 | 0.0571 |
Mycobacterium leprae | PROBABLE NADH DEHYDROGENASE NDH | 0.0083 | 0.1754 | 0.4152 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0112 | 0.2798 | 0.9375 |
Trypanosoma brucei | apurinic/apyrimidinic endonuclease, putative | 0.004 | 0.016 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.2179 | 0.7788 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0112 | 0.2798 | 0.9375 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0095 | 0.2179 | 1 |
Echinococcus multilocularis | thioredoxin glutathione reductase | 0.0037 | 0.006 | 0.0215 |
Trypanosoma cruzi | trypanothione reductase, putative | 0.0037 | 0.0042 | 0.2643 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0095 | 0.2179 | 0.7788 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Onchocerca volvulus | 0.0035 | 0 | 0.5 | |
Mycobacterium tuberculosis | Probable nitrite reductase [NAD(P)H] large subunit [FAD flavoprotein] NirB | 0.0083 | 0.1754 | 0.2515 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.004 | 0.016 | 0.0229 |
Loa Loa (eye worm) | glutathione reductase | 0.0037 | 0.0042 | 0.0194 |
Trichomonas vaginalis | ap endonuclease, putative | 0.004 | 0.016 | 0.016 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.004 | 0.016 | 0.0733 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0112 | 0.2798 | 1 |
Schistosoma mansoni | ap endonuclease | 0.004 | 0.016 | 0.0535 |
Mycobacterium tuberculosis | Probable reductase | 0.0083 | 0.1754 | 0.2515 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.004 | 0.016 | 0.0378 |
Trypanosoma brucei | trypanothione reductase | 0.0037 | 0.0042 | 0.2643 |
Entamoeba histolytica | hypothetical protein | 0.0112 | 0.2798 | 0.2681 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0095 | 0.2179 | 0.7301 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0112 | 0.2798 | 1 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0309 | 1 | 1 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.0151 | 0.4223 | 0.6058 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.004 | 0.016 | 1 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Toxoplasma gondii | thioredoxin reductase | 0.0037 | 0.0042 | 0.2643 |
Mycobacterium tuberculosis | Probable dehydrogenase | 0.0083 | 0.1754 | 0.2515 |
Brugia malayi | glutathione reductase | 0.0037 | 0.0042 | 0.0151 |
Loa Loa (eye worm) | thioredoxin reductase | 0.0037 | 0.0042 | 0.0194 |
Entamoeba histolytica | hypothetical protein | 0.0112 | 0.2798 | 0.2681 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0095 | 0.2179 | 0.7788 |
Brugia malayi | hypothetical protein | 0.0112 | 0.2798 | 1 |
Schistosoma mansoni | ap endonuclease | 0.004 | 0.016 | 0.0535 |
Entamoeba histolytica | hypothetical protein | 0.0112 | 0.2798 | 0.2681 |
Mycobacterium tuberculosis | NADPH-dependent mycothiol reductase Mtr | 0.0037 | 0.0042 | 0.0061 |
Onchocerca volvulus | 0.0035 | 0 | 0.5 | |
Toxoplasma gondii | exonuclease III APE | 0.004 | 0.016 | 1 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.004 | 0.016 | 1 |
Plasmodium vivax | thioredoxin reductase, putative | 0.0037 | 0.0042 | 0.2643 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.0151 | 0.4223 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.004 | 0.016 | 0.0571 |
Onchocerca volvulus | 0.0035 | 0 | 0.5 | |
Mycobacterium tuberculosis | Probable NADH dehydrogenase Ndh | 0.0083 | 0.1754 | 0.2515 |
Entamoeba histolytica | hypothetical protein | 0.0112 | 0.2798 | 0.2681 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0309 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.004 | 0.016 | 0.5 |
Leishmania major | apurinic/apyrimidinic endonuclease-redox protein | 0.004 | 0.016 | 1 |
Treponema pallidum | fructose-bisphosphate aldolase | 0.0309 | 1 | 1 |
Mycobacterium tuberculosis | Probable oxidoreductase | 0.0093 | 0.2094 | 0.3003 |
Mycobacterium tuberculosis | Dihydrolipoamide dehydrogenase LpdC (lipoamide reductase (NADH)) (lipoyl dehydrogenase) (dihydrolipoyl dehydrogenase) (diaphoras | 0.0093 | 0.2094 | 0.3003 |
Leishmania major | trypanothione reductase | 0.0037 | 0.0042 | 0.2643 |
Trypanosoma cruzi | apurinic/apyrimidinic endonuclease | 0.004 | 0.016 | 1 |
Plasmodium vivax | glutathione reductase, putative | 0.0037 | 0.0042 | 0.2643 |
Mycobacterium tuberculosis | Putative ferredoxin reductase | 0.0083 | 0.1754 | 0.2515 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0095 | 0.2179 | 0.7788 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.0151 | 0.4223 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.